BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yu JS, Chung JJ, Kim JH, Kim KW. Small hypervascular hepatocellular carcinomas: value of "washout" on gadolinium-enhanced dynamic MR imaging compared to superparamagnetic iron oxide-enhanced imaging. Eur Radiol 2009;19:2614-22. [PMID: 19513719 DOI: 10.1007/s00330-009-1465-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Ouedraogo W, Tran-Van Nhieu J, Baranes L, Lin SJ, Decaens T, Laurent A, Djabbari M, Pigneur F, Duvoux C, Kobeiter H. [Evaluation of noninvasive diagnostic criteria for hepatocellular carcinoma on pretransplant MRI (2010): correlation between MR imaging features and histological features on liver specimen]. J Radiol. 2011;92:688-700. [PMID: 21819911 DOI: 10.1016/j.jradio.2011.03.020] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
2 Cereser L, Furlan A, Bagatto D, Girometti R, Como G, Avellini C, Orsaria M, Zuiani C, Bazzocchi M. Comparison of portal venous and delayed phases of gadolinium-enhanced magnetic resonance imaging study of cirrhotic liver for the detection of contrast washout of hypervascular hepatocellular carcinoma. J Comput Assist Tomogr 2010;34:706-11. [PMID: 20861773 DOI: 10.1097/RCT.0b013e3181e1a88e] [Cited by in Crossref: 24] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
3 Sherman M. The radiological diagnosis of hepatocellular carcinoma. Am J Gastroenterol. 2010;105:610-612. [PMID: 20203642 DOI: 10.1038/ajg.2009.663] [Cited by in Crossref: 37] [Cited by in F6Publishing: 33] [Article Influence: 3.1] [Reference Citation Analysis]
4 Malliaras K, Smith RR, Kanazawa H, Yee K, Seinfeld J, Tseliou E, Dawkins JF, Kreke M, Cheng K, Luthringer D. Validation of contrast-enhanced magnetic resonance imaging to monitor regenerative efficacy after cell therapy in a porcine model of convalescent myocardial infarction. Circulation. 2013;128:2764-2775. [PMID: 24061088 DOI: 10.1161/circulationaha.113.002863] [Cited by in Crossref: 80] [Cited by in F6Publishing: 50] [Article Influence: 8.9] [Reference Citation Analysis]
5 Hwang J, Kim SH, Lee MW, Lee JY. Small (≤ 2 cm) hepatocellular carcinoma in patients with chronic liver disease: comparison of gadoxetic acid-enhanced 3.0 T MRI and multiphasic 64-multirow detector CT. Br J Radiol 2012;85:e314-22. [PMID: 22167508 DOI: 10.1259/bjr/27727228] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 4.3] [Reference Citation Analysis]
6 Choi J, Cho HC, Sun M, Kim HC, Sirlin CB. Indeterminate Observations (Liver Imaging Reporting and Data System Category 3) on MRI in the Cirrhotic Liver: Fate and Clinical Implications. American Journal of Roentgenology 2013;201:993-1001. [DOI: 10.2214/ajr.12.10007] [Cited by in Crossref: 41] [Cited by in F6Publishing: 8] [Article Influence: 4.6] [Reference Citation Analysis]
7 Park VY, Choi JY, Chung YE, Kim H, Park MS, Lim JS, Kim KW, Kim MJ. Dynamic enhancement pattern of HCC smaller than 3 cm in diameter on gadoxetic acid-enhanced MRI: comparison with multiphasic MDCT. Liver Int 2014;34:1593-602. [PMID: 24673802 DOI: 10.1111/liv.12550] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 1.6] [Reference Citation Analysis]
8 Zheng R, Wang L, Wang C, Yu X, Chen W, Li Y, Li W, Yan F, Wang H, Li R. Feasibility of automatic detection of small hepatocellular carcinoma (≤2 cm) in cirrhotic liver based on pattern matching and deep learning. Phys Med Biol 2021;66. [PMID: 33780910 DOI: 10.1088/1361-6560/abf2f8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Chung J, Yu JS, Kim DJ, Chung JJ, Kim JH, Kim KW. Hypervascular hepatocellular carcinoma in the cirrhotic liver: diffusion-weighted imaging versus superparamagnetic iron oxide-enhanced MRI. Magn Reson Imaging 2011;29:1235-43. [PMID: 21907517 DOI: 10.1016/j.mri.2011.07.025] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
10 Baek KA, Kim SS, Shin HC, Hwang JA, Choi SY, Lee WH, Park CH, Lee HN, Heo NH. Gadoxetic acid-enhanced MRI for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: can hypointensity on the late portal venous phase be used as an alternative to washout? Abdom Radiol (NY) 2020;45:2705-16. [PMID: 32382820 DOI: 10.1007/s00261-020-02553-z] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Tan CH, Low SC, Thng CH. APASL and AASLD Consensus Guidelines on Imaging Diagnosis of Hepatocellular Carcinoma: A Review. Int J Hepatol. 2011;2011:519783. [PMID: 22007313 DOI: 10.4061/2011/519783] [Cited by in Crossref: 40] [Cited by in F6Publishing: 45] [Article Influence: 3.6] [Reference Citation Analysis]
12 Ba-ssalamah A, Qayyum A, Bastati N, Fakhrai N, Herold CJ, Caseiro Alves F. P4 radiology of hepatobiliary diseases with gadoxetic acid-enhanced MRI as a biomarker. Expert Review of Gastroenterology & Hepatology 2013;8:147-60. [DOI: 10.1586/17474124.2014.876359] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]